The weekly litigation news digest is live. Subscribe now

Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen

Patent No. EP3689383 (titled "Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen") was filed by The United States OF America on Mar 15, 2013. The application was issued on Dec 31, 2025.

Patent Summary

UPC Cases New

Latest UPC cases involving this patent.

Case NumberFiling DatePlaintiffProceeding Type
UPC_CFI_0000029/2026Jan 5, 20262Seventy BIOInfringement

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BOULT WADE TENNANTDec 31, 2025BOULT WADE TENNANT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3689383

THE UNITED STATES OF AMERICA
Application Number
EP19216091A
Filing Date
Mar 15, 2013
Status
Granted And Under Opposition
Nov 28, 2025
Publication Date
Dec 31, 2025